Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma
- 1 May 2004
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (4) , 433-439
- https://doi.org/10.1016/j.ejso.2004.01.015
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic Factors After Isolated Limb Infusion With Cytotoxic Agents for MelanomaAnnals of Surgical Oncology, 2002
- Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanomaJournal of the American College of Surgeons, 1999
- Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusionSeminars in Surgical Oncology, 1998
- Frequency and duration of remission after isolated limb perfusion for melanoma.Archives of Surgery, 1997
- Thirty-five years of isolated limb perfusion for melanoma: Indications and resultsBritish Journal of Surgery, 1996
- Determinants of acute regional toxicity following isolated limb perfusion for melanomaMelanoma Research, 1996
- A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limbCancer, 1993
- Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limbEuropean Journal Of Cancer, 1993
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958